Christopher Koh MD MHSc
Hepatology & Liver Transplantation
Clinical Director, NIDDK, NIH
Join to View Full Profile
10 Center DrCrc Bldg-10, Rm. 5-2740Bethesda, MD 20892
Phone+1 301-443-9402
Dr. Koh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MarylandFellowship, Gastroenterology, 2010 - 2013
Duke University School Of MedicineMHSc, Clinical Research, 2009 - 2012
NIH Clinical Center2007 - 2010
MedStar Health Georgetown University/Harbor HospitalChief Residency, Internal Medicine, 2006 - 2007- MedStar Health Georgetown University/Harbor HospitalResidency, Internal Medicine, 2004 - 2007
Saba University School of MedicineClass of 2004
Certifications & Licensure
MD State Medical License 2007 - 2026
Clinical Trials
- Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C Start of enrollment: 2014 Mar 20
Publications & Presentations
PubMed
- 1 citationsEffects of Metreleptin in Patients With Generalized Lipodystrophy Before vs After the Onset of Severe Metabolic Disease.Maiah Brush, Sungyoung Auh, Elaine Cochran, Rebecca Tuska, Christopher Koh
The Journal of Clinical Endocrinology and Metabolism. 2025-03-17 - Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.Dina Halegoua-DeMarzio, Victor J Navarro, Ashley Davis, Jawad Ahmad, Bharathi Avula
Drug Safety. 2025-02-01 - Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice.Sarah Duehren, Takuro Uchida, Masataka Tsuge, Nobuhiko Hiraga, Susan L Uprichard
Virus Research. 2024-11-01
Press Mentions
Superior Athleticism: Is It in Your Genes? By Colleen LabbeJuly 31st, 2015
Eiger Biopharmaceuticals Enrolls First Patient in Trial for Hepatitis D TherapyAugust 10th, 2018
Risk Factors Can Help Spot People Who Need Hep D ScreeningNovember 17th, 2020
Grant Support
- Multidisciplinary Collaborative Clinical Research, Protocol Navigation, Monitoring Compliance, and Other Clinical Services in NIDDK Program Area DiseasesNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent
- Management and Treatment of Chronic Delta Hepatitis Infection and other Liver DiseasesNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent
- Management and Treatment of Chronic Delta Hepatitis Infection and other Liver DiseasesNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent
Professional Memberships
- Member
- Member
- American Association For The Study Of Liver DiseasesMember
Other Languages
- Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
